Dr. Maarten van Cleeff Elected New President of TB Alliance Stakeholders Association
The Global Alliance for TB Drug Development (TB Alliance) today announced the election of Dr. Maarten van Cleeff as President
The Global Alliance for TB Drug Development (TB Alliance) today announced the election of Dr. Maarten van Cleeff as President
New York, NY– January 11, 2010 The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership
GUANGZHOU, China, Jan 6 (Reuters) – China, saddled with the world’s second largest tuberculosis burden after India, is fighting an
UNITAID is a global health initiative, established to provide sustainable, predictable and additional funding to significantly impact on market dynamics
CANCUN, Mexico (Reuters) – In Uganda, health experts are getting laboratories ready and preparing villagers in two districts for a
On World AIDS Day, it is important to recognize the tragedy of HIV/AIDS, the millions of lives that it has
The TB community voice is essential to stopping the epidemic. Here, a health worker, activist, and TB Alliance Community Engagement
Findings from an assessment of global clinical trial sites and mycobacteriology labs for their capacity to conduct registration-standard TB drug
On October 8, 2009, the TB Alliance and Research!America co-sponsored a Capitol Hill Briefing in the US Senate chambers entitled,
Treatment shortening would be welcomed as a primary goal for future TB drug regimens, according to a new study from